NCCTG Overall Organization - Grothey
-
Upload
terrybear11 -
Category
Documents
-
view
526 -
download
1
description
Transcript of NCCTG Overall Organization - Grothey
![Page 1: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/1.jpg)
Patient Advocacy SymposiumJune 9, 2008
Axel Grothey, MDGroup Vice Chair
![Page 2: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/2.jpg)
CP1223393-2
3 Trial design and conduct• To improve clinical trial design and conduct
1 Improved therapeutics• To improve the duration and quality of life
of cancer patients
Specific Aims
22 Translational research• To improve the understanding of cancer biology
and the biological consequences of treatment
4 Cancer prevention and control• To provide an infrastructure for studies of cancer
prevention and symptom management
![Page 3: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/3.jpg)
CP1223393-3
IdeaGenerators
NCCTGPrograms
NCCTGLeadership
NCCTG Organizational Overview
MCCC and other academic centers
Cooperativegroups
Industry
NCI
CommunityOncologists
CommunityOncologyPrograms
CommunityOncologyPrograms
![Page 4: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/4.jpg)
CP1223393-4
Community-Based Partnership
![Page 5: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/5.jpg)
NCCTG in 1977
WA
ORID
MT
Saskatchewan
WY
UTNV
CA
AZ NM
CO
NE
SD
NDMN
MOKS
FL
NC
MI
KY
OH
VA
PA
NY
ME
NHVT
IAIL
WI
Ontario
Mexico
GA
TX LA
ARAL
TN
MS
OK SC
IN
WV
AK
MDDE
NJCT
RI
MA
PR
HI
DC
![Page 6: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/6.jpg)
CP1223393-6
The 43 NCCTG Memberships Are The 43 NCCTG Memberships Are Headquartered in 28 States & CanadaHeadquartered in 28 States & Canada
AK
HI
PR
WA
ORID
MT
Saskatchewan
WY
UTNV
CA
AZ NM
CO
NE
SD
NDMN
MOKS
FL
NC
MI
KYWV VA
PA
NY
MDDE
NJCT
RI
MA
ME
NHVT
IAIL
WI
DC
GA
TX LA
ARAL
TN
MS
OK SC
IN OH
![Page 7: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/7.jpg)
CP1223393-7
NCCTG has >340 treating locations in 33 NCCTG has >340 treating locations in 33 states as well as Canada & Puerto Ricostates as well as Canada & Puerto Rico(Pending/newly approved treating locations in red states)
AK
WA
ORID
MT
Saskatchewan
WY
UTNV
CA
AZ NM
CO
NE
SD
NDMN
MOKS
FL
NC
MI
KY
OH
VA
PA
NY
MDDE
NJCT
RI
MA
ME
NHVT
IA
19
12
5
6
3
IL
WI
DC
37
25
17
45
2
425
2
4
HI
GA10
TX LA
ARAL
TN
MS
OK
2 2
6
1
16
SC3
IN
1
14
916 WV
1
PR
21
1
1
2
2
2
2
4
AK
WA
ORID
MT
Saskatchewan
WY
UTNV
CA
AZ NM
CO
NE
SD
NDMN
MOKS
FL
NC
MI
KY
OH
VA
PA
NY
MDDE
NJCT
RI
MA
ME
NHVT
IA
19
12
5
6
3
IL
WI
DC
37
25
17
45
2
425
2
4
HI
GA10
TX LA
ARAL
TN
MS
OK
2 2
6
1
16
SC3
IN
1
14
916 WV
1
PR
21
1
1
2
2
2
2
4
AK
WA
ORID
MT
Saskatchewan
WY
UTNV
CA
AZ NM
CO
NE
SD
NDMN
MOKS
FL
NC
MI
KY
OH
VA
PA
NY
MDDE
NJCT
RI
MA
ME
NHVT
IA
19
12
5
6
3
IL
WI
DC
37
25
17
45
2
425
2
4
HI
GA10
TX LA
ARAL
TN
MS
OK
2 2
6
1
16
SC3
IN
1
14
916 WV
1
PR
21
1
1
2
2
2
2
4
AK
WA
ORID
MT
Saskatchewan
WY
UTNV
CA
AZ NM
CO
NE
SD
NDMN
MOKS
FL
NC
MI
KY
OH
VA
PA
NY
MDDE
NJCT
RI
MA
ME
NHVT
IA
19
12
5
6
3
IL
WI
DC
37
25
17
45
2
425
2
4
HI
GA10
TX LA
ARAL
TN
MS
OK
2 2
6
1
16
SC3
IN
1
14
916 WV
1
PR
21
1
1
2
2
2
2
4
![Page 8: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/8.jpg)
8
New members since last meeting
• Keith Lanier, MD – Columbia River CCOP, Portland, OR
• Meera Ravidranathan, MD – New Mexico MBCCOP, Richmond, VA
• Mary Helen Hackney, MD – Virginia Commonwealth MBCCOP, Richmond, VA
• Marianne Lange, MD – Grand Rapids Clinical Oncology Program, Grand Rapids, MI
• Jacqueline Vuky, MD – Virginia Mason Research Center CCOP, Seattle, WA
![Page 9: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/9.jpg)
CP1223393-9
Membership and Governance
Membership• 32 CCOPs• 11 Non-CCOPs
Executive CommitteeMembership PI and Modality Co-Chairs• Chair: J. Kugler – Peoria, IL• Vice Chair: P. Stella – Ann Arbor,
MI
![Page 10: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/10.jpg)
CP1223393-10
Membership and Governance
Membership• 32 CCOPs• 11 Non-CCOPs
Executive CommitteeMembership PI and Modality Co-Chairs• Chair: J. Kugler – Peoria, IL• Vice Chair: P. Stella – Ann Arbor,
MI
![Page 11: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/11.jpg)
CP1223393-11
Community Member Involvement
• Co-Chairs of scientific committees
• Participate in protocol review
• Co-chairs of protocols
• Audits
• Patient Advocate Network
![Page 12: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/12.jpg)
CP1223393-12
Community Accrualand Data Quality
• 78% of NCCTG accrual fromthe community
• Every NCCTG coordinated trial in last grant period opened and accrued patients at a community site
• Since 2003: 60 audits; 1 unacceptable
![Page 13: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/13.jpg)
13
ASCO Community Participation Award Nominees 2008
Preston D. Steen, M.D.
MeritCare Hospital CCOP
Fargo, ND
Roscoe F. Morton, M.D.Iowa Oncology Research
Association CCOPDes Moines, IA
![Page 14: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/14.jpg)
CP1223393-14
NCCTG Organizational Overview
NCCTGLeadership
IdeaGenerators
Clinical data
Biospecimens
MCCC and other academic centers
Cooperativegroups
Industry
NCI
CommunityOncologists
CommunityOncologyPrograms
CommunityOncologyPrograms
![Page 15: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/15.jpg)
CP1223393-15
Mayo Clinic Cancer Center
• Leadership
• Integrated systems
• Financial support
![Page 16: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/16.jpg)
CP1223393-16
Mayo Clinic Cancer Center
• Leadership
• Integrated systems
• Financial support
![Page 17: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/17.jpg)
CP1223393-17
Mayo Clinic Cancer Center
• Leadership
• Integrated systems
• Financial support
![Page 18: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/18.jpg)
NCCTG Committees
Discipline-Oriented Scientific
• Cancer Control
• Novel Therapeutics
• Quality of Life
Modality
• Pathology
• Radiation Oncology
• Surgery
Core Function
• Audit
• Cancer Health Disparity
• Oncology Nursing
• Clinical Research Assoc Board
• Patient Advocates
Statistics and Data Center
• Biostatistics
Advisory
• Translational Research Coord
Loprinzi Martenson Jatoi Brown
Goetz Erlichman Adjei Galanis
Halyard Grothey Jatoi Brown
Visscher Smyrk Aubry Scheithauer
Halyard Martenson Schild Brown
Pockaj Cima Nichols New
Perotti Pearson Garces Leitch
Greder Finck DeKrey Kowbell
Mahacek Barnick Rogers Dillavou
Smith DeLucca Keller Buckmeier
Dueck Sargent Mandrekar Ballman
Goetz Sinicrope Molina Jenkins
Breast Gastrointestinal Lung Neuro-oncology
Disease Specific
LIAISONS
![Page 19: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/19.jpg)
CP1223393-19
Protocol Activity2001-2005
NCCTG-led 61• Actively accruing 28• In development 24• Closed, in follow up 103
NCCTG-endorsed 65
![Page 20: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/20.jpg)
CP1223393-20
Accrual to NCCTG Trials2001-2005
NCCTG-led• Patients
8,631• NCCTG member accrual
3,952
NCCTG-endorsed• NCCTG member accrual
3,307
![Page 21: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/21.jpg)
CP1223393-21
NCCTG Manuscripts – 2001-2006(Published and Accepted)
Total 217
• NEJM 5
• JNCI 4
• JCO 60
![Page 22: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/22.jpg)
CP1223393-22
Abstracts and PresentationsASCO 2001-2007
Total 229
• Plenary 2
• Oral 63
• Poster discussion 66
• Poster 80
• Publication 18
![Page 23: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/23.jpg)
CP1223393-23
ASCO Abstracts 2008
Oral
Poster Discussion
Poster
Publication
Pending
10 9
14 11
17 16
6 6
2 0
49 42
Numbers in red are NCCTG-Led
![Page 24: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/24.jpg)
24
ASCO Abstracts 2008
BrainBreastCancer ControlGILungNovel TherapeuticsQOLStatistical Methods
Numbers in red are NCCTG-Led Studies
(4 ASCO GI)
3 29 67 715 136 53 34 42 249 42
![Page 25: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/25.jpg)
CP1223393-25
Aim 1 Improved Therapeutics Future Plans
THEPATIENT
Targeted
therapiesChemo-
therapy
Radiation Surgery
Measureof Success
Measureof Success
Survival
AND
Quality of Life
![Page 26: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/26.jpg)
CP1223393-26
Aim 2 Translational Research Future Plans
THE PATIENT
PatientBiology
Pharmaco-genomics
Immunology
TumorBiology
Tumortissue
biomarkers
![Page 27: NCCTG Overall Organization - Grothey](https://reader036.fdocuments.us/reader036/viewer/2022070301/5462c1deaf7959477b8b50a2/html5/thumbnails/27.jpg)
CP1223393-27
NCCTGHigh-quality science
• Practice-changing therapies• Clinically meaningful translational results• Influential methodologic analyses• Active cancer control research
Committed to collaboration• Community oncology and
academic centers